Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p.m.
The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.
Sun Pharma's Q3 earnings may see a slight setback in margins, pressured by increased R&D expenses and a lower contribution ...
Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...
Pharmaceutical Technology on MSN9h
Novo Nordisk secures FDA approval for Ozempic in diabetes with CKDThe new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
We recently published a list of 10 Unstoppable Stocks to Buy in 2025. In this article, we are going to take a look at where ...
Latin Times on MSN3h
Elizabeth Warren Goes After RFK Jr. in Tense Exchange Over His Lawsuits Against Pharma Companies: 'Kids Might Day But Robert Kennedy Can Keep Cashing In'The Democratic senator asked the HHS nominee to commit to not sue pharmaceutical companies or take profit from lawsuits ...
Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...
The company started the first phrase of its operation in the city in January at the David Lust Accelerator Building on the Elevate Rapid City campus.
Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...
It is incumbent not only on people to have the willingness to learn, but also on pharmaceutical and scientific industries to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback